J 2023

Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging

ZATECKY, Jan, Oldřich COUFAL, Miloš HOLÁNEK, Otakar KUBALA, Marketa KEPICOVA et. al.

Basic information

Original name

Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging

Authors

ZATECKY, Jan (203 Czech Republic), Oldřich COUFAL (203 Czech Republic, belonging to the institution), Miloš HOLÁNEK (203 Czech Republic, belonging to the institution), Otakar KUBALA (203 Czech Republic), Marketa KEPICOVA (203 Czech Republic), Jiri GATEK (203 Czech Republic), Milan LERCH (203 Czech Republic) and Matus PETEJA (203 Czech Republic)

Edition

TURKISH JOURNAL OF SURGERY, TURKEY, TURKISH SURGICAL ASSOC, 2023, 2564-6850

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Turkey

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 0.600 in 2022

RIV identification code

RIV/00216224:14110/23:00133908

Organization unit

Faculty of Medicine

UT WoS

000946256700003

Keywords in English

Breast cancer; sentinel lymph node biopsy; neoadjuvant chemotherapy; axillary dissection; level I axillary dissection

Tags

International impact, Reviewed
Změněno: 5/4/2024 09:39, Mgr. Tereza Miškechová

Abstract

V originále

Objective: The purpose of the study was to investigate the oncological sufficiency of level I axillary dissection for adequate histological nodal staging (ypN) in patients with breast cancer and tumor-involved sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC).